TABLE 4.
Univariate and multivariate Cox regression analysis for ATa recurrence.
| Factor | Patients without ATs recurrence | Patients with ATs recurrence | Univarite analysis |
Multivariable |
||
| P | HR | P | HR | |||
| Lower AI (Group C, %) | 26 (32.9) | 4 (36.4) | 0.84 | 1.06 (0.58–1.97) | 0.65 | 1.17 (0.59–2.32) |
| Age | 62.53 | 62.95 | 0.48 | 1.02 (0.96–1.09) | 0.10 | 1.07 (0.99–1.16) |
| CHA2DS2-VASc | 2.23 | 2.27 | 0.50 | 0.86 (0.57–1.32) | 0.42 | 0.77 (0.41–1.45) |
| HAS-BLED | 0.92 | 0.99 | 0.69 | 0.85 (0.40–1.84) | 0.49 | 0.69 (0.23–2.03) |
| LA | 36.12 | 36.34 | 0.71 | 1.03 (0.88–1.20) | 0.16 | 1.14 (0.95–1.37) |
| BMI | 23.35 | 24.14 | 0.70 | 0.97 (0.82–1.14) | 0.81 | 0.98 (0.80–1.19) |
| Male | 50.00 | 7 | 0.96 | 1.03 (0.30–3.05) | 0.79 | 0.81 (0.17–3.81) |
| Diabetes | 12 | 0 | 0.39 | 0.04 (0.00–67.4) | 0.98 | 0.00 (0.00–) |
| Hypertension | 49 | 4 | 0.39 | 0.58 (0.17–1.99) | 0.22 | 0.37 (0.07–1.84) |
| CHD | 15 | 1 | 0.46 | 0.46 (0.06–3.61) | 0.74 | 0.67 (0.06–7.39) |
| Smoke | 29 | 4 | 1.00 | 1.00 (0.29–3.41) | 0.36 | 2.32 (0.38–14.21) |
| CKD | 14 | 1 | 0.51 | 0.52 (0.06–3.92) | 0.89 | 1.21 (0.09–16.76) |
| LVEF | 68.56 | 68.76 | 0.50 | 1.03 (0.94–1.14) | 0.32 | 1.07 (0.94–1.21) |
AI, ablation index; Ata, atrial tachyarrhythmia; LA, left atrium; BMI, body mass index; CHD, coronary heart disease; CKD, chronic kidney disease; LVEF, left ventricular ejection fraction.